Dr. Cohen received his M.D. from the University of Pennsylvania School of Medicine. He completed internal medicine residency training at the Massachusetts General Hospital and then obtained fellowship training in adult hematology and medical oncology at the Dana-Farber/Brigham and Women’s and Massachusetts General Hospital combined fellowship program. Following fellowship, he became an Instructor at the MGH where his research focused on the role of angiogenic progenitor cells in tumor vascular biology.
I am a hematologist who specializes in treating patients with bleeding and clotting disorders. I have been seeing patients with HHT since 2007. I treat anemia as well as providing systemic treatments such as IV bevacizumab. I work in conjunction with other providers in the University of Michigan Health Systems to provide multidisciplinary care for patients with HHT.
Dr. Al-Samkari is Co-Director of the Massachusetts General Hospital HHT Center of Excellence and an Associate Professor of Medicine at Harvard Medical School. He is a hematologist who specializes in bleeding and clotting disorders, with a specific focus in bleeding disorders and HHT. In addition to management of bleeding, he specializes in management of anemia associated with HHT, typically due to severe and often refractory iron deficiency. He has seen and treated several hundred patients with HHT with bleeding and/or anemia.
